Set a clear monthly limit on how many 'essential copies' a 503A compounder may produce to ensure consistency and reduce litigation.
I will set a clear monthly limit on how many 'essential copies' a 503A compounder may produce to ensure consistency and reduce litigation.
Occurrences
Evidence
Key provisions say the bill would "Set a clear monthly limit on how many 'essential copies' a 503A compounder may produce to ensure consistency and reduce litigation." The press release says Banks introduced the SAFE Drugs Act this week and that the bill would strengthen existing guardrails in the Food, Drug, and Cosmetic Act.
The legislation page lists "02-26-2026 | S.3794 | SAFE Drugs Act of 2026" with "Latest Action: Read twice and referred to the Committee on Health, Education, Labor, and Pensions."
Assessments
Banks introduced the SAFE Drugs Act of 2026 containing the promised monthly limit for 503A compounders, and the bill was referred to the Senate HELP Committee. The record shows introduction and referral only, with no evidence that the monthly limit was enacted or otherwise implemented. This is a serious legislative attempt during his federal Senate term, but it does not fulfill the promised outcome.